Clinical Oncology
Volume 19, Issue 7 , Pages 481-489 , September 2007

Defining the Need for Breast Cancer Radiotherapy in the General Population: a Criterion-based Benchmarking Approach

  • M. Kerba

      Affiliations

    • Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Ontario, Canada, K7L 3N6
    • The Cancer Centre of Southeastern Ontario, Kingston, Ontario, Canada, K7L 5P9
    • Present address: Tom Baker Cancer Centre, 1331-29 Street, N.W., Calgary, Alberta T2N-4N2, Canada.
    • ,
  • Q. Miao

      Affiliations

    • Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Ontario, Canada, K7L 3N6
    • ,
  • J. Zhang-Salomons

      Affiliations

    • Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, Kingston, Ontario, Canada, K7L 3N6
    • ,
  • W. Mackillop

      Affiliations

    • The Cancer Centre of Southeastern Ontario, Kingston, Ontario, Canada, K7L 5P9
    • Corresponding Author InformationAuthor for correspondence: William J. Mackillop, Division of Cancer Care and Epidemiology, Queen's University Cancer Research Institute, 10 Stuart Street, Kingston, Ontario K7L 2V7, Canada. Tel: +1-613-533-6895; Fax: +1-613-533-6686.

Received 30 August 2006 ,Revised 22 February 2007 ,Accepted 6 March 2007.

References 

  1. National Cancer Institute of Canada . Canadian cancer statistics 2001. Toronto: National Cancer Institute of Canada; 2001;
  2. Delaney G, Jacob S, Barton M. Estimating the optimal external-beam radiotherapy utilization rate for genitourinary malignancies. Cancer. 2005;103(3):462–473
  3. Ontario Cancer Treatment and Research Foundation . A plan for radiation treatment, Province of Ontario, 1995–2000. Toronto: Ontario Cancer Treatment and Research Foundation; 1995;
  4. Duncan W, Jenkin D. A report to the Ontario Treatment and Research Foundation and the Ontario Cancer Institute. Ontario: Radiation Oncology Commission; 1990;
  5. Delaney G, Jacob S, Featherstone C, Barton M. The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer. 2005;104(6):1129–1137
  6. Frodin JE, Jonsson E, Moller T, et al. Radiotherapy in Sweden: a study of present use in relation to the literature and an estimate of future trends. Acta Oncol. 1996;35(8):967–979
  7. Mackillop WJ, Groome PA, Zhang-Salomons J, et al. Does a centralized radiotherapy system provide adequate access to care?. J Clin Oncol. 1997;15(3):1261–1271
  8. Mackillop WJ, Dixon P, Zhou Y, et al. Variations in the management and outcome of non-small cell lung cancer in Ontario. Radiother Oncol. 1994;32(2):106–115
  9. Denham JW. How do we bring an acceptable level of radiotherapy services to a dispersed population?. Australas Radiol. 1995;39(2):171–173
  10. Foroudi F, Tyldesley S, Barbera L, Huang J, Mackillop WJ. Evidence-based estimate of appropriate radiotherapy utilization rate for prostate cancer. Int J Radiat Oncol Biol Phys. 2003;55(1):51–63
  11. Sanderson C, Hunter D, McKee M, et al. Limitations of epidemiologically based needs assessment: the case of prostatectomy. Med Care. 1997;35(7):669–685
  12. Wright J. Health needs assessment in practice. London: BMJ Publishing Group; 1998;
  13. Foroudi F, Tyldesley S, Walker H, et al. An evidence-based estimate of appropriate radiotherapy utilization rate for breast cancer. Int J Radiat Oncol Biol. 2002;53(5):1240–1253
  14. Tyldesley S, Boyd C, Schulze K, et al. Estimating the need for radiotherapy for lung cancer: an evidence-based epidemiological approach. Int J Radiat Oncol Biol Phys. 2001;49(4):973–985
  15. Foroudi F, Tyldesley S, Barbera L, et al. An evidence-based estimate of the appropriate radiotherapy utilization rate for colorectal cancer. Int J Radiat Oncol Biol Phys. 2003;56(5):1295–1307
  16. Usmani N, Foroudi F, Du J, et al. An evidence-based estimate of the appropriate rate of utilization of radiotherapy for cancer of the cervix. Int J Radiat Oncol Biol Phys. 2005;63(3):812–827
  17. Bogan CE, English MJ. Benchmarking for best practices: winning through innovative adaptation. 1st edn. New York: McGraw-Hill; 1994;
  18. Aday LA, Begley C, Lairson DR, et al. Evaluating the healthcare system: effectiveness, efficiency, and equity. 2nd edn. Ann Arbor: Health Administration Press; 1998;
  19. Barbera L, Zhang-Salomons J, Huang J, et al. Defining the need for radiotherapy for lung cancer in the general population. A criterion-based, benchmarking approach. Med Care. 2003;41(9):1074–1085
  20. Statistics Canada . Demographic statistics. http://www.statcan.ca/Daily/English/050928/d050928a.htm2005;
  21. Robles SC, Marrett LD, Clarke EA, et al. An application of capture–recapture methods to the estimation of completeness of cancer registration. J Clin Epidemiol. 1988;41(5):495–501
  22. Clarke EA, Marrett LD, Kreiger N. Cancer registration in Ontario: a computer approach. IARC Sci Publ. 1991;95:246–257
  23. Cancer Care Ontario . Cancer patients being treated closer to home. http://www.cancercare.on.ca/index_newsReleases2001.htm2001;
  24. Surveillance, Epidemiology, and End Results (SEER) Program. SEER 1973–2002 public-use data (http://seer.cancer.gov/publicdata/). National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, Washington, DC, 2005.
  25. Nattinger AB, McAuliffe TL, Schapira MM. Generalizability of the surveillance, epidemiology, and end results registry population: factors relevant to epidemiologic and health care research. J  Clin Epidemiol. 1997;50(8):939–945
  26. Howe HL. Cancer incidence in North America, 1988–1991. Sacramento, CA: North American Association of Central Cancer Registries; 1995;
  27. Huang J, Zhou S, Groome P, et al. Factors affecting the use of palliative radiotherapy in Ontario. J Clin Oncol. 2001;19(1):137–144
  28. World Health Organization . International classification of disease, revised, Vol. I. Geneva: WHO; 1977;
  29. In:  Percy C,  Van Holten C,  Muir C editor. International classification for oncology (ICD-O). 2nd edn. Geneva: WHO; 1990;
  30. Fritz A, Ries L. The SEER program code manual. Bethesda: National Institutes of Health; 1998;
  31. Armitage P, Berry G. Statistical methods in medical research. 3rd edn. Oxford: Blackwell Scientific Publications; 1994;
  32. Krasnik A, Groenewegen PP, Pedersen PA, et al. Changing remuneration systems: effects on activity in general practice. Br Med J. 1990;300(6741):1698–1701
  33. Hemenway D, Killen A, Cashman SB, et al. Physicians' responses to financial incentives. Evidence from a for-profit ambulatory care center. N Engl J Med. 1990;322(15):1059–1063
  34. Evans RG. Supplier-induced demand: some empirical evidence and implications. In:  Perlman M editors. The economics of health and medical care. New York: John Wiley and Sons; 1974;p. 162–173
  35. Lievens Y, Van Den Bogaert W, Rijnders A, et al. Palliative radiotherapy practice within western European countries: impact of the radiotherapy financing system?. Radiother Oncol. 2000;56(3):289–295
  36. McGowan T. Private management of a public service: what can be learned from the CROS experience?. Hosp Quart. 2003;6(4):33–38
  37. Whelan TJ, Lada BM, Laukkanen E, et al. Breast irradiation in women with early stage invasive breast cancer following breast conservation surgery. Provincial breast disease site group. Cancer Prev Control. 1997;1(3):228–240
  38. Lazovich D, Solomon CC, Thomas DB, et al. Breast conservation therapy in the United States following the 1990 National Institutes of Health consensus development conference on the treatment of patients with early stage invasive breast carcinoma. Cancer. 1999;86(4):628–637
  39. Nagel G, Rohrig B, Hoyer H, et al. A population-based study on variations in the use of adjuvant radiotherapy in breast cancer patients. Strahlenther Onkol. 2002;178(11):589–596
  40. Hillner BE, Penberthy L, Desch CE, et al. Variation in staging and treatment of local and regional breast cancer in the elderly. Breast Cancer Res Treat. 1996;40(1):75–86
  41. Hebert-Croteau N, Brisson J, Latreille J, et al. Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women. Cancer. 1999;85(5):1104–1113
  42. Ballard-Barbash R, Potosky AL, Harlan LC, et al. Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst. 1996;88(11):716–726
  43. Richardson LC, Schulman J, Sever LE, et al. Early-stage breast cancer treatment among medically underserved women diagnosed in a national screening program, 1992–1995. Breast Cancer Res Treat. 2001;69(2):133–142
  44. Hillner BE, McDonald MK, Penberthy L, et al. Measuring standards of care for early breast cancer in an insured population. J Clin Oncol. 1997;15(4):1401–1408
  45. Tyldesley S, Zhang-Salomons J, Groome PA, et al. Association between age and the utilization of radiotherapy in Ontario. Int J Radiat Oncol Biol Phys. 2000;47(2):469–480
  46. Ostelind K, Hansen HH, Hansen HS, et al. Chemotherapy versus chemotherapy plus radiotherapy in limited small cell lung cancer. Results of a controlled trial with 5 years follow-up. Br J Cancer. 1986;54(1):7–17
  47. Murray N, Coy P, Pater JL, et al. Importance of timing of thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. J Clin Oncol. 1993;11(2):336–344
  48. Mazur DJ, Merz JF. How older patients' treatment preferences are influenced about therapeutic uncertainty: surgery versus expectant management for localized prostate cancer. J Am Ger Soc. 1996;44(8):934–937
  49. Rothenbacher D, Lutz MP, Porzsolt F. Treatment decisions in palliative cancer care: patients' preferences for involvement and doctors' knowledge about it. Eur J Cancer. 1997;33(8):1184–1189
  50. McGinnis LS, Menck HR, Eyre HJ, et al. National cancer data base survey of breast cancer management for patients from low income zip codes. Cancer. 2000;88(4):933–945
  51. Hynes DM. The quality of breast cancer care in local communities: implications for health care reform. Med Care. 1994;32(4):328–340
  52. Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002;94(7):490–496
  53. Samet JM, Hunt WC, Farrow DC. Determinants of receiving breast-conserving surgery. The surveillance, epidemiology, and end results program, 1983–1986. Cancer. 1994;73(9):2344–2351
  54. Mor V, Laliberte LL, Petrisek AC, et al. Impact of breast cancer treatment guidelines on surgeon practice patterns: results of a hospital-based intervention. Surgery. 2000;128(5):847–861
  55. Polsky D, Mandelblatt JS, Weeks JC, et al. Economic evaluation of breast cancer treatment: considering the value of patient choice. J Clin Oncol. 2003;21:1139–1146
  56. Malin JL, Schneider EC, Epstein AM, et al. Results of the national initiative for cancer care quality: how can we improve the quality of cancer care in the United States. J Clin Oncol. 2006;24(4):626–634
  57. Yabroff KR, Kerner JF. Variations in surgery for early-stage breast cancer: what are we measuring?. Lancet. 2005;366(9481):188–190
  58. Gregorio DI, Kulldorff M, Barry L, et al. Geographic differences in primary therapy for early stage breast cancer. Ann Surg Oncol. 2001;8(10):844–849
  59. Baldwin LM, Taplin SH, Friedman H, Moe R. Access to multidisciplinary cancer care: is it linked to the use of breast-conserving surgery with radiation for early-stage breast carcinoma?. Cancer. 2004;100(4):701–709
  60. Richards MA, Parrott JC. Tertiary cancer services in Britain: benchmarking study of activity and facilities at 12 specialist centres. Br Med J. 1996;313(7053):347–349

PII: S0936-6555(07)00583-3

doi: 10.1016/j.clon.2007.03.013

Clinical Oncology
Volume 19, Issue 7 , Pages 481-489 , September 2007

Article Tools

* Image Usage & Resolution